Z

Zur Rose Group AG
SIX:ROSE

Watchlist Manager
Zur Rose Group AG
SIX:ROSE
Watchlist
Price: 32.3 CHF -5.56%
Market Cap: 405m CHF

Operating Margin
Zur Rose Group AG

-8.3%
Current
-9%
Average
3.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-8.3%
=
Operating Profit
-133.9m
/
Revenue
1.6B

Operating Margin Across Competitors

No Stocks Found

Zur Rose Group AG
Glance View

Market Cap
374.9m CHF
Industry
Retail

Zur Rose Group AG engages in the operation of an e-commerce pharmacy. The company is headquartered in Frauenfeld, Thurgau and currently employs 2,131 full-time employees. The company went IPO on 2017-07-06. The firm focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The firm's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The firm operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

ROSE Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-8.3%
=
Operating Profit
-133.9m
/
Revenue
1.6B
What is the Operating Margin of Zur Rose Group AG?

Based on Zur Rose Group AG's most recent financial statements, the company has Operating Margin of -8.3%.

Back to Top